ask="0.70"
ask_size="3700"
average_daily_volume="490192"
bid="0.65"
bid_size="300"
book_value="1.64"
change="-0.04"
change_from_200_day_moving_average="-0.43"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-2.73"
change_From_52_week_low="0.12"
change_in_percent="-5.80%"
close="0.65"
dividend_pay_date="8/19/2015"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.59"
ebitda="-16.45M"
eps_estimate_current_year="-1.52"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.24"
ex_dividend_date="8/20/2015"
float_shares="5356000"
high="0.70"
high_52_weeks="3.38"
last_trade_date="1/9/2017"
last_trade_price="0.65"
last_trade_size="100"
last_trade_time="4:00pm"
low="0.65"
low_52_weeks="0.53"
market_capitalization="7.82M"
moving_average_200_day="1.08"
moving_average_50_day="0.70"
name="Catalyst Biosciences
Inc."
notes="N/A"
one_year_target_price="3.25"
open="0.69"
pe_ratio="N/A"
peg_ratio="0.02"
percent_change_from_200_day_moving_average="-39.70%"
percent_change_from_50_day_moving_average="-7.74%"
percent_change_from_52_week_high="-80.77%"
percent_change_from_52_week_low="+22.57%"
previous_close="0.69"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.42"
price_per_sales="18.99"
revenue="437000.00"
shares_outstanding="12026000"
short_ratio="0.09"
stock_exchange="NCM"
symbol="CBIO"
volume="98981"
weeks_range_52="0.53 - 3.38"
